Methods of administering a dermatological agent to a subject

Details Methods of administering a dermatological agent to a subject Methods of administering a dermatological agent to a subject

2011-02-15

2011-02-15

Wax, Robert A (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

C424S485000

Reexamination Certificate

active

07887842

ABSTRACT:
Methods for administering a dermatological agent to a subject are provided. In the subject methods an effective amount of a topical formulation of the dermatological agent is topically applied to a host. The topically applied formulation of dermatological agent is then occluded with a hydrogel patch, where a feature of the hydrogel patch is that it lacks a pharmaceutically active agent. Also provided are methods of treating a subject for a disease condition by administering a dermatological agent to the subject. Also provided are kits for use in practicing the subject methods. The subject methods and compositions find use in a variety of different applications.

REFERENCES:
patent: 3891757 (1975-06-01), Higuchi
patent: 4009282 (1977-02-01), Voorhees
patent: 4909244 (1990-03-01), Quarfoot et al.
patent: 4917890 (1990-04-01), McAnalley
patent: 5013769 (1991-05-01), Murray et al.
patent: 5076265 (1991-12-01), Wokalek
patent: 5695777 (1997-12-01), Donovan et al.
patent: 5897880 (1999-04-01), Drizen et al.
patent: 5902827 (1999-05-01), Pamukcu et al.
patent: 6147102 (2000-11-01), Borgman
patent: 6348212 (2002-02-01), Hymes et al.
patent: 6455065 (2002-09-01), Hymes
patent: 6645520 (2003-11-01), Hsu et al.
patent: 1243437 (2000-02-01), None
patent: 1302608 (2001-07-01), None
patent: 4006628 (1990-03-01), None
patent: 0 630 629 (1994-05-01), None
patent: 1216908 (1968-03-01), None
patent: 1020010096776 (2001-11-01), None
patent: WO 98/30214 (1998-07-01), None
patent: WO 99/04829 (1999-02-01), None
patent: WO 01/30345 (2001-05-01), None
patent: WO 2004/030696 (2004-04-01), None
Castelijns, et al. The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin relapsing psoriasis. Dec. 9, 1998, Department of Dermatology, University Hospital Nijmegen, pp. 901-909.
Castelljns, F.A.C.M., et al., “Efficacy of Calcipotriol Ointment Applied Under Hydrocolloid Occlusion in Psoriasis.” Dermatology (2002); 200: pp. 25-30.
C.P. Glade, et al., “Flow Cytometric Assessment of Clearance and Relapse Characteristics in Psoriasis Vulgaris After Treatment With Weekly Clobetasol Lotion Under Hydrocolloid Occlusion Versus Twice-Daily Clobetasol Ointment.” Skin Phannacol Appl. Skin Physical (2002); 15: pp. 92-99.
Duweb G.A. et al., “Occlusive Versus Nonocclusive Calcipotriol Ointment Treatment for Palmoplantar Psoriasis.” Int. J. Tissue React (2001) 23(2): pp. 59-62.
Marsland AM, Griffiths CE ., “Treatments for Chronic Palmoplantar Pustular Psoriasis.” Skin Therapy Lett (2001) Nov. 6(12); pp. 3-5.
Mommers, J.M., et al., “Clobetasol Under Hydrocolloid Occlusion in Psoriasis Results in a Complete Block of Proliferation and in a Rebound of Lesions Following Discontinuation.” Dermatology 1999; 199: pp. 323-327.
Scher R.K. et al., “Tazarotene 0.1% Gel in The Treatment of Fingernail Psoriasis: A Double-Blind, Randomized, Vehicle-Controlled Study.” Cutis (2001) Nov.; 68(5): pp. 355-358.
Taylor Ks, et al., “Pituitary-Adrenal Function Following Topical Triamcinolone Acetonide and Occlusion.” Arch Dermatology (1965) Aug.; 92(2): pp. 174-177.
Van der Vleuten CJ, et al., “Clobetasol-17-Propionate Lotion Under Hydrocolloid Dressing (Duoderm ET) Once Weekly Versus Unoccluded Clobetasol-17-Propionate Ointment Twice Daily in Psoriasis: An Immunohistocheniical Study on Remission and Relapse.” Archives of Dermatological Research (1999) Jul.-Aug.; pp. 291(7-8): 390-395.
Volden G. et al., “Remission and Relapse of Chronic Plaque Psoriasis Treated Once a Week With Clobetasol Propionate Occluded With a Hydrocolloid Dressing Versus Twice Daily Treatment With Clobetasol Propionate Alone.” Journal of Dermatology Treat (2001) Sep.:12 (3); pp. 141-144.
Agren et al., A comparative study of three occlusive dressings in the treatment of full-thickness wounds in pigs, J. Am. Acad. Dermato., 1997, 36:53-58.
Bello et al., Practical treatment of body and open leg wounds of horses with bovine collagen, biosynthetic wound dressing and cyanoacrylate, J. of Equine Veterinary Science, 2002; 22(4), 157-164.
Castelijins et al., The epidermal phenotype during initiation of the psoriatic lesion in the symptomless margin of relapsing psoriasis, J. Am. Acad. Dermatol. 1999; 40:901-909.

Affiliated with

Also associated with

Rating

Methods of administering a dermatological agent to a subject does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of administering a dermatological agent to a subject, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of administering a dermatological agent to a subject will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2634332